Tirzepatide Is amazing for weight loss

Diabetes and obesity are a vicious cycle. Diabetic patients are often accompanied by Obesity, especially type 2 diabetes, and most of them have significantly Elevated BMI. Obesity will cause many harms to the human body. The harm of Obesity is that it will cause metabolic abnormalities in the human body, Increase the load on the heart, brain, liver and kidneys and other organs, and Cause high blood pressure, disease, cerebrovascular disease, diabetes, and Kidney disease. The risk of chronic non-infectious diseases such as syndrome, Fatty liver, and tumors...

According to the results of the SURMOUNT-1 study presented at the American Diabetes Association Scientific Sessions (ADA), among non-diabetic overweight/obese Adults, the highest dose group of Tirzepatide (15 mg) lost an average of 48 Pounds of weight at 72 weeks. the effect is comparable to Surgery.
Tirzepatide injection is a new type of glucagon-like peptide-1 Receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) dual Receptor channel agonist. It integrates two types of insulin-stimulating effects into a single molecule, and activates two incretin receptors, GIP and GLP-1, Which are involved in blood sugar control through a dual mechanism of action, to Achieve hypoglycemic or weight loss effects.